VMLY&R HEALTH announces Patrick Beers in new role as Executive Director and Market Access Strategy lead
This latest leadership hire further advances the agency’s expanding health offering under its connected brands positioning.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
UK to offer COVID booster to all adults from September
/in R&D, TherapeuticsAll adults in the United Kingdom will be offered a COVID-19 booster starting from September, health officials said, hours after the country became the first in the world to approve an Omicron-adapted shot.
AstraZeneca says data confirms Enhertu benefit in breast cancer patients
/in R&D, TherapeuticsAstraZeneca said a late-stage trial had confirmed the benefit of breast cancer drug Enhertu in patients with an advanced form of the disease who had been previously treated with another therapy.
Seagen loses patent battle against Daiichi Sankyo as Merck waits in the wings
/in R&D, TherapeuticsAs the biotech world awaits the announcement of Merck’s anticipated buyout of Seagen, an arbitrator came down on the side of Daiichi Sankyo in a patent battle against the Seattle-based biotech.
Novartis’ canakinumab rough patch continues with Phase III NSCLC flop
/in R&D, TherapeuticsOn Monday, Novartis released results from the Phase III CANOPY-A trial, showing that its candidate canakinumab (ACZ885) failed to meet its primary efficacy endpoint in adult non-small cell lung cancer (NSCLC) patients.
BrainStorm’s ALS drug heads to the FDA with correction to Phase III analyses
/in TherapeuticsIn what has been a long time coming, Tel Aviv and New York-based BrainStorm announced Monday that it would submit a Biologics License Application (BLA) to the FDA for NurOwn as a potential treatment for ALS. Simultaneously, BrainStorm announced corrected analyses it says strengthen its original conclusions.
Novavax seeks U.S. authorization for COVID vaccine booster
/in Business, TherapeuticsNovavax Inc. said on Monday it had filed for U.S. authorization for use of its COVID-19 vaccine as a booster dose in people who had either received its shots or a different vaccine.
UK first to approve Omicron COVID shot with Moderna go-ahead
/in TherapeuticsUK’s Joint Committee on Vaccination and Immunisation agency will now decide how shot should be deployed. In addition Moderna anticipates Australia, Canada, and EU approvals soon.
Pfizer CEO Bourla shows mild symptoms after testing positive for COVID
/in Business, TherapeuticsPfizer Inc. Chief Executive Officer Albert Bourla said on Monday he had tested positive for COVID-19 and was experiencing very mild symptoms.
40 years later, business of healthcare changed in very personal ways
/in August 2022, Issue Archives, Marketing & AdvertisingTechnology has transformed the industry, significantly expanding pharma pipelines, facilitating more engagement, and empowering patients.